Filing Details

Accession Number:
0001209191-20-036289
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-12 16:32:31
Reporting Period:
2020-06-10
Accepted Time:
2020-06-12 16:32:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1446847 Ironwood Pharmaceuticals Inc IRWD () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1224341 S Lawrence Olanoff C/O Ironwood Pharmaceuticals, Inc.
100 Summer Street, Suite 2300
Boston MA 02110
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2020-06-10 11,350 $10.06 68,629 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.80 to $10.78,inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and ExchangeCommission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in thisfootnote.